Description
- Abstract:
- Several policy initiatives could help to ensure that low-income Americans benefit from 340B drug price savings. Transparency initiatives that elucidate how hospitals use 340B revenues to benefit low-income patients are the most politically feasible first step towards reining in the program. Requiring hospitals to disclose this information allows policymakers and researchers to have greater oversight over the sprawling program, putting pressure on hospitals to have greater integrity with the use of their savings.
Access Conditions
- Use and Reproduction
- All rights reserved
- Rights
- In Copyright
- Restrictions on Use
- All Rights Reserved
Citation
Christopher Whaley, and Corrie Mook,
"340B Drug Pricing Program: Potential Policy Options to Restore Program Integrity"
(2025).
Center for Advancing Health Policy through Research (CAHPR) Digital Collection.
Brown Digital Repository. Brown University Library.
https://doi.org/10.26300/8n7w-8p14
Relations
Collection:
-
Center for Advancing Health Policy through Research (CAHPR) Digital Collection
This collection contains research outputs produced by members of the Center for Advancing Health Policy through Research (CAHPR). Collection DOI: https://doi.org/10.26300/mshb-sp27...